Complete and partial responses of the TEMPI syndrome to bortezomib

New England Journal of Medicine

Volumn 367, Issue 8, 2012, Pages 778-780

  Schroyens, Wilfried ^a   O'Connell, Casey ^b   Sykes, David B ^c  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; ERYTHROPOIETIN; IMMUNOGLOBULIN G KAPPA PARAPROTEIN; PARAPROTEIN; UNCLASSIFIED DRUG;

AMBIENT AIR; BLOOD OXYGEN TENSION; DRUG EFFICACY; DRUG RESPONSE; FENESTRATION; HUMAN; KIDNEY DISEASE; LETTER; MULTIPLE CYCLE TREATMENT; PERINEPHRIC FLUID COLLECTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REMISSION; SYSTEMIC DISEASE; TELANGIECTASIA ELEVATED ERYTHROPOIETIN LEVEL AND ERYTHROCYTOSIS MONOCLONAL GAMMOPATHY PERINEPHRIC FLUID COLLECTION INTRAPULMONARY SHUNTING SYNDROME;

EID: 84865280270     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1205806     Document Type: Letter

References (2)

1. Sykes DB, Schroyens W, O'Connell C. The TEMPI syndrome - a novel multisystem disease. N Engl J Med 2011;365:475-7.
2. Kwok M, Korde N, Landgren O. Bortezomib to treat the TEMPI syndrome. N Engl J Med 2012;366:1843-5.